HIMS:NYSE, Hims & Hers Health, Inc.

HIMS stock overview

Hims & Hers Health, Inc. (HIMS:NYSE) closed at $27.71 on October 23, 2026, down 4.87% on the day. The stock trades 45.7% below its 52-week high of $50.99 and 101.7% above its 52-week low of $13.74. Over the past year, it lost 43.2%. Hims & Hers Health, Inc. is part of the Finance sector.

Key figures

Price: $27.71
Day change: -4.87%
Volume: 9,808,715
Average volume: 11,701,379
Market cap: 6B+
52-week range: $13.74 – $50.99
50-day average: $29.16
200-day average: $27.17

Price action over the past year

In 252 trading sessions since October 23, 2025, HIMS closed higher on 110 days (44%). Its best day was March 9, 2026 (+40.79%) and its worst was February 9, 2026 (-16.03%). The stock moved 10% or more in a single session 18 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

Oct 23, 2026: Trading sideways between $27.71 and $30.92 over 30 days (Sideways scanner)
Oct 23, 2026: Hit a new 1-Month Low of $27.71 (New Highs/Lows scanner)
Oct 23, 2026: News catalyst: Investor Update (News Catalysts scanner)
Aug 21, 2026: Spiked to $34.46 on 14M+ shares (Spikes scanner)

HIMS news

Oct 24, 2026: Hims & Hers Health (HIMS) Debuts Injectable And Oral Testosterone Therapies
Oct 23, 2026: Hims & Hers Health, Inc. (HIMS) Declines More Than Market: Some Information for Investors
Oct 23, 2026: Market Chatter: Hims & Hers Health Bids Judge to Toss Federal Trade Commission Complaint
Oct 23, 2026: Kaplan Fox Encourages Hims & Hers Health, Inc. (HIMS) Investors to Contact the Firm About Their Legal Rights Before November 2, 2026
Oct 23, 2026: Hims & Hers Stock Has Barely Moved Since Its Biggest Men's Health Launch. Here's What November 9 Has to Show
Oct 23, 2026: What Snap-On (SNA) Said on Its Q3 Earnings Call
Oct 22, 2026: Telehealth Firm Hims & Hers Seeks Dismissal Of FTC Privacy And Subscription Lawsuit
Oct 22, 2026: What Does Progyny's Falling Multiple Really Say?

About Hims & Hers Health, Inc.

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.

Similar stocks

Find more stocks like HIMS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.